biotech

Vitespen (Oncophage) Vaccine Shows Promising Results Against Glioma

Filed in archive Drugs, Vaccines and Therapeutics on November 17, 2006

Vitespen (Oncophage) Vaccine Shows Promising Results Against Glioma
Scientists from the UCSF Medical Center have shown that vitespen (trademarked as Oncophage), a vaccine developed for the treatment of glioma seems to be effective. Glioma, a type of tumor arising from glial cells, commonly involves the brain.
Derived from each individual's tumor, vitespen contains the "fingerprint" of the patient's particular cancer and is designed to reprogram the body's immune system to target only cancer cells bearing this fingerprint. The vaccine is intended to leave healthy tissue unaffected and limit the debilitating side effects typically associated with traditional cancer treatments such as chemotherapy and radiation therapy.

Vitespen is also on trials, and has received fast track and orphan drug designations from the Food and Drug Administration, in both metastatic melanoma (skin cancer) and renal cell carcinoma (kidney cancer).
More details of the clinical trials from the UCSF report.

[Photo: Antigenics]

Permalink: Vitespen (Oncophage) Vaccine Shows Promising Results Against Glioma

Tags: vaccine  glioma  brain+tumor  tumor  cancer  oncophage  vitespen  biotech  oncophage+vaccine 

Vote for Vitespen (Oncophage) Vaccine Shows Promising Results Against Glioma:

  • Currently 8.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.00 out of 7 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells